Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MDLN, SARO, PHAT, INVH, PONY, and represent 99.82% of Carlyle Group's stock portfolio.
- Added to shares of these 5 stocks: SPWR, REPX, NBIS, METC, HOOD.
- Started 3 new stock positions in NBIS, METC, REPX.
- Reduced shares in these 6 stocks: QTTB (-$13M), CUBE (-$8.1M), HTFL, SYRE, XCUR, INVH.
- Sold out of its positions in SYRE, CUBE, XCUR, HTFL.
- Carlyle Group was a net seller of stock by $-20M.
- Carlyle Group has $10B in assets under management (AUM), dropping by -5.82%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Carlyle Group
Carlyle Group holds 19 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Medline Com Cl A (MDLN) | 73.8 | $7.4B | 187M | 39.44 |
|
|
| Standardaero (SARO) | 25.3 | $2.5B | 85M | 29.91 |
|
|
| Phathom Pharmaceuticals (PHAT) | 0.4 | $38M | 3.5M | 10.85 |
|
|
| Invitation Homes (INVH) | 0.2 | $20M | 663k | 30.21 |
|
|
| Pony Ai Sponsored Ads (PONY) | 0.2 | $16M | 2.4M | 6.95 |
|
|
| Getty Images Holdings Cl A Com (GETY) | 0.1 | $5.4M | 6.2M | 0.86 |
|
|
| Spruce Biosciences Com New (SPRB) | 0.0 | $2.1M | 39k | 54.00 |
|
|
| Complete Solaria (SPWR) | 0.0 | $1.6M | +441% | 2.3M | 0.69 |
|
| Adicet Bio Com New (ACET) | 0.0 | $1.6M | 184k | 8.64 |
|
|
| Forward Air Corp (FWRD) | 0.0 | $1.4M | 107k | 13.51 |
|
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.0 | $1.2M | 270k | 4.56 |
|
|
| Krispy Kreme (DNUT) | 0.0 | $1.2M | 341k | 3.53 |
|
|
| Q32 Bio (QTTB) | 0.0 | $769k | -94% | 60k | 12.74 |
|
| Riley Exploration Permian In (REPX) | 0.0 | $530k | NEW | 16k | 32.96 |
|
| Nebius Group Shs Class A (NBIS) | 0.0 | $510k | NEW | 1.8k | 276.17 |
|
| Robinhood Mkts Com Cl A (HOOD) | 0.0 | $475k | +40% | 4.7k | 100.28 |
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $449k | 1.1M | 0.42 |
|
|
| N-able Common Stock (NABL) | 0.0 | $344k | 94k | 3.67 |
|
|
| Ramaco Res Com Cl A (METC) | 0.0 | $288k | NEW | 22k | 13.23 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2026 Q2 filed Aug. 7, 2026
- Carlyle Group 2026 Q1 filed May 8, 2026
- Carlyle Group 2025 Q4 filed Feb. 13, 2026
- Carlyle Group 2025 Q3 filed Nov. 7, 2025
- Carlyle Group 2025 Q2 filed Aug. 8, 2025
- Carlyle Group 2025 Q1 filed May 9, 2025
- Carlyle Group 2024 Q4 filed Feb. 13, 2025
- Carlyle Group 2024 Q3 filed Nov. 8, 2024
- Carlyle Group 2024 Q2 filed Aug. 9, 2024
- Carlyle Group 2024 Q1 filed May 3, 2024
- Carlyle Group 2023 Q4 filed Feb. 2, 2024
- Carlyle Group 2023 Q3 filed Nov. 3, 2023
- Carlyle Group 2023 Q2 filed Aug. 4, 2023
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022